The evamist product ramp up continues to improve,however you would have to wonder how long kv can continue as a going concern as they do not appear to have fda sign off yet and they are running out of money.It is my understanding if kv goes broke the evamist distribution goes back to acrux for no cost.Kv paid 150 million for the product and one would anticipate that there would be a number of pharma companies who would like to get their hands on this product and be prepared to pay for the priviledge.
- Forums
- ASX - By Stock
- ACR
- kv pharmaceuticals and evamist
kv pharmaceuticals and evamist
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ACR (ASX) to my watchlist
|
|||||
Last
6.1¢ |
Change
0.000(0.00%) |
Mkt cap ! $17.73M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 152642 | 5.9¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
6.1¢ | 100000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 152642 | 0.059 |
3 | 126241 | 0.058 |
2 | 100908 | 0.055 |
1 | 88000 | 0.054 |
1 | 197000 | 0.051 |
Price($) | Vol. | No. |
---|---|---|
0.061 | 100000 | 1 |
0.062 | 216145 | 2 |
0.063 | 100000 | 1 |
0.064 | 12500 | 1 |
0.065 | 130000 | 1 |
Last trade - 16.12pm 04/09/2024 (20 minute delay) ? |
Featured News
ACR (ASX) Chart |
Day chart unavailable